title: Reduction of vascular endothelial growth factor a in human breast milk after intravitreal injection of bevacizumab but not ranibizumab.
authors.affiliation: Department of Ophthalmology, University Eye Hospital Freiburg, Freiburg, Germany. christoph.ehlken@uniklinik-freiburg.de
authors.forename: Christoph
authors.initials: C
authors.lastname: Ehlken
authors.forename: Gottfried
authors.initials: G
authors.lastname: Martin
authors.forename: Andreas
authors.initials: A
authors.lastname: Stahl
authors.forename: Hansjürgen Thomas
authors.initials: HT
authors.lastname: Agostini
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000009:adverse effects* / Q000097:blood; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008895:Milk, Human / Q000378:metabolism*; D000069579:Ranibizumab; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab